Urinary antiseptics in asymptomatic bacteriuria of pregnancy.
A screening programme for the detection of asymptomatic bacteriuria in patients attending an antenatal clinic is described. The results obtained from the use of urinary antiseptics in a controlled trial over a period of two years are presented. The number of patients developing clinical pyelonephritis, fetal maturity at delivery and birth weight were recorded for treatment and control groups and compared with the equivalent results obtained from the total population of patients seen at the clinic.
D000022:Abortion, Spontaneous / Q000453:epidemiology; D000757:Anencephaly / Q000453:epidemiology; D001437:Bacteriuria / Q000188:drug therapy* / Q000453:epidemiology; D001724:Birth Weight; D002986:Clinical Trials as Topic; D005260:Female; D005313:Fetal Death / Q000453:epidemiology; D005865:Gestational Age; D006626:Hippurates / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D008333:Mandelic Acids / Q000627:therapeutic use; D008709:Methenamine / Q000627:therapeutic use*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000453:epidemiology; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D011645:Puerperal Infection / Q000453:epidemiology; D011704:Pyelonephritis / Q000453:epidemiology
D006626:Hippurates; D008333:Mandelic Acids; D008709:Methenamine